Arysta and Plant Health Care End Development and License Agreement
1 December 2015 Biological products supplier Plant Health Care and crop protection company Arysta LifeScience, have agreed to terminate the product development and license agreement that enabled Arysta to sell combination products containing Plant Health Care’s Harpin αβ protein technology combined with Arysta LifeScience’s crop protection products in the U.S. row crop market.
“Challenging conditions in agricultural markets driven by weak crop prices, especially in row crops, coupled with focus on the organizational merger of Chemtura, AgroSolutions, Agriphar, and Arysta LifeScience contributed to an unsuccessful launch of the first combination product under the agreement,” according to Plant Health Care.
The companies continue to work together to bring Plant Health Care’s technology to market in Brazil through foliar applications on sugarcane and to seek other opportunities for global collaboration.
Get The Newsletter Today!
